Is Pentostatin in shortage right now?

Yes. FDA currently lists Pentostatin in shortage. This page is rebuilt every morning from FDA's shortage database.

Who makes Pentostatin?

3 companies have marketed Pentostatin in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Market view

pentostatin · Powder

2 marketed package NDCs · 2 active manufacturers

All forms Powder (2)Injection, Powder, Lyophilized, For Solution (1)

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for pentostatin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

NipentAug 28, 2026
New shortageby this manufacturer
Hospira, Inc., a Pfizer Company's Nipent (Injection, 10 mg, single dose vial) is newly in shortage — other3 companies market nipent · 1 has products in shortage
Aug 28, 2026

Same drug class

Other molecules FDA puts in Nucleoside Metabolic Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Pentostatin in shortage right now?: Yes. FDA currently lists Pentostatin in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Pentostatin?: 3 companies have marketed Pentostatin in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.